Loading people...
Chloe Zhang is a Principal at Vivo Capital based in Hong Kong, where she focuses on healthcare and life sciences investments alongside sustainability initiatives. Before this, she served as a Director in Leveraged Finance at China Orient Asset Management International Limited. Her earlier career includes financial roles at Bank of China Group Investment Limited and the New York office of Ernst and Young. During her tenure in asset management, Zhang managed a portfolio reaching a peak assets under management of HK$4.5 billion and established a private equity fund with US$300 million in assets. She holds regulatory licenses as a Responsible Officer for Type 4 and 9 from the Hong Kong Securities and Futures Commission. Her current focus centers on executing cross-border transactions, pre-IPO financing, and leveraged debt structures across the biotechnology and medical device sectors.
Chloe Zhang is a distinguished Principal at Vivo Capital, a global healthcare investment firm renowned for its expertise in the life sciences sector. In her pivotal role, Chloe is instrumental in Vivo Capital's mission to identify, evaluate, and nurture groundbreaking companies that are shaping the future of healthcare. Her responsibilities encompass a broad spectrum of activities, including comprehensive due diligence on potential investments, in-depth market analysis, and active engagement with portfolio companies to foster their growth and strategic development.
Vivo Capital's investment strategy spans various stages, from early-stage venture capital to growth equity and buyouts, primarily focusing on biopharmaceuticals, medical devices, diagnostics, digital health, and healthcare services. Chloe Zhang's contributions are vital in navigating these complex and rapidly evolving segments of the healthcare industry. She brings a keen analytical mind and a deep understanding of market dynamics to assess opportunities that align with Vivo Capital's long-term vision of supporting innovation that addresses unmet medical needs and improves patient outcomes globally.
While specific details of Chloe Zhang's career background are not publicly detailed, her position as a Principal at a firm like Vivo Capital suggests a robust professional journey marked by significant experience in finance, science, or healthcare operations. Professionals in such roles typically possess strong analytical capabilities, a profound understanding of scientific and clinical development processes, and a proven track record in evaluating investment opportunities. Her expertise likely plays a crucial role in Vivo Capital's rigorous investment process, helping the firm make informed decisions that drive value for its investors and portfolio companies.
Vivo Capital has a long history of successful investments across North America and Asia, leveraging its extensive network and deep industry knowledge. Chloe Zhang is an integral part of the team that contributes to this impressive track record. She works closely with entrepreneurs and management teams, providing strategic guidance and operational support to help companies scale, achieve regulatory milestones, and ultimately bring innovative products and services to market. Her dedication to fostering innovation within the healthcare ecosystem underscores Vivo Capital's commitment to making a tangible impact on global health. Through her work, Chloe Zhang helps to advance the firm's reputation as a leading investor dedicated to transforming healthcare through strategic capital and expert partnership.
Chloe Zhang is a Principal at Vivo Capital, a global healthcare investment firm. She plays a key role in identifying, evaluating, and supporting innovative companies in the life sciences and healthcare sectors.
As part of Vivo Capital, Chloe Zhang focuses on investments across the healthcare and life sciences industries. This includes areas such as biopharmaceuticals, medical devices, diagnostics, digital health, and healthcare services, spanning various investment stages from venture to growth equity.
Chloe Zhang works as a Principal at Vivo Capital, a leading global healthcare investment firm with a strong presence in both North America and Asia.
